24.03.2010 - Swiss drugs industry supplier Lonza is in talks to buy over 5% stake in India's Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)